These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29547034)

  • 1. Effects of pH on the Antibiotic Resistance of Bacteria Recovered from Diabetic Foot Ulcer Fluid
    McArdle CD; Lagan KM; McDowell DA
    J Am Podiatr Med Assoc; 2018 Jan; 108(1):6-11. PubMed ID: 29547034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CODIFI (Concordance in Diabetic Foot Ulcer Infection): a cross-sectional study of wound swab versus tissue sampling in infected diabetic foot ulcers in England.
    Nelson A; Wright-Hughes A; Backhouse MR; Lipsky BA; Nixon J; Bhogal MS; Reynolds C; Brown S;
    BMJ Open; 2018 Jan; 8(1):e019437. PubMed ID: 29391370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Novel Collagen Wound Model To Simulate the Activity and Distribution of Antimicrobials in Soft Tissue during Diabetic Foot Infection.
    Price BL; Lovering AM; Bowling FL; Dobson CB
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6880-6889. PubMed ID: 27620475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic Resistance in Diabetic Foot Soft Tissue Infections: A Series From Greece.
    Demetriou M; Papanas N; Panagopoulos P; Panopoulou M; Maltezos E
    Int J Low Extrem Wounds; 2017 Dec; 16(4):255-259. PubMed ID: 29110552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae isolates recovered from hospitalized patients in Germany.
    Seifert H; Körber-Irrgang B; Kresken M;
    Int J Antimicrob Agents; 2018 Feb; 51(2):227-234. PubMed ID: 28705666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
    Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microbiology of diabetic foot infections in patients recently treated with antibiotic therapy: A prospective study from India.
    Rastogi A; Sukumar S; Hajela A; Mukherjee S; Dutta P; Bhadada SK; Bhansali A
    J Diabetes Complications; 2017 Feb; 31(2):407-412. PubMed ID: 27894749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological profile of diabetic foot ulcers in Kuwait.
    Alhubail A; Sewify M; Messenger G; Masoetsa R; Hussain I; Nair S; Tiss A
    PLoS One; 2020; 15(12):e0244306. PubMed ID: 33378365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers.
    Harkless L; Boghossian J; Pollak R; Caputo W; Dana A; Gray S; Wu D
    Surg Infect (Larchmt); 2005; 6(1):27-40. PubMed ID: 15865549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of bactericidal effects of bacteriophage and gentamicin combination regimen against Staphylococcus aureus and Pseudomonas aeruginosa strains in a mice diabetic wound model.
    Jokar J; Abdulabbas HT; Javanmardi K; Mobasher MA; Jafari S; Ghasemian A; Rahimian N; Zarenezhad A; ُSoltani Hekmat A
    Virus Genes; 2024 Feb; 60(1):80-96. PubMed ID: 38079060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperacillin/tazobactam therapy for diabetic foot infection.
    Zeillemaker AM; Veldkamp KE; van Kraaij MG; Hoekstra JB; Hoynck van Papendrecht AA; Diepersloot RJ
    Foot Ankle Int; 1998 Mar; 19(3):169-72. PubMed ID: 9542990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of wound pH on the antibacterial properties of Medical Grade Honey when applied to bacterial isolates present in common foot and ankle wounds. An in vitro study.
    McArdle C; Coyle S; Santos D
    J Foot Ankle Res; 2023 Oct; 16(1):66. PubMed ID: 37784205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriology of diabetic foot.
    El-Tahawy AT
    Saudi Med J; 2000 Apr; 21(4):344-7. PubMed ID: 11533815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection.
    Ginn AN; Wiklendt AM; Gidding HF; George N; O'Driscoll JS; Partridge SR; O'Toole BI; Perri RA; Faoagali J; Gallagher JE; Lipman J; Iredell JR
    PLoS One; 2012; 7(6):e38719. PubMed ID: 22761698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial Profile and Antibiotic Susceptibility Pattern in Diabetic Patients with Mild, Moderate, and Severe Foot Infections in Tehran.
    Taki E; Jabalameli F; Mohajeri Tehrani MR; Feizabadi MM; Beigverdi R; Emaneini M
    Arch Razi Inst; 2022 Oct; 77(5):1925-1933. PubMed ID: 37123144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in antibiotic resistance in diabetic foot infections among peruvian patients: a single-center cross-sectional study.
    Moya-Salazar J; Chamana JM; Porras-Rivera D; Goicochea-Palomino EA; Salazar CR; Contreras-Pulache H
    Front Endocrinol (Lausanne); 2023; 14():1267699. PubMed ID: 38116313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal piperacillin/tazobactam in the management of multidrug-resistant Pseudomonas aeruginosa endophthalmitis.
    Pathengay A; Mathai A; Shah GY; Ambatipudi S
    J Cataract Refract Surg; 2010 Dec; 36(12):2210-1. PubMed ID: 21111328
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibiotic sensitivity of the main opportunistic pathogenic aerobic bacteria].
    Minukhin VV; Tsyganenko AIa; Kravtsova VI; Arkushenko LL; Stepanenko TV
    Antibiot Khimioter; 1990 Mar; 35(3):36-8. PubMed ID: 2113800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperacillin/tazobactam in treatment of brain abscess.
    Javad A; Vahid P; Kazem G; Alireza S; Gholamali G; Qulamreza K
    Scand J Infect Dis; 2006; 38(3):224-6. PubMed ID: 16500789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers.
    Nelson EA; O'Meara S; Craig D; Iglesias C; Golder S; Dalton J; Claxton K; Bell-Syer SE; Jude E; Dowson C; Gadsby R; O'Hare P; Powell J
    Health Technol Assess; 2006 Apr; 10(12):iii-iv, ix-x, 1-221. PubMed ID: 16595081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.